These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 26548988

  • 1. Synthesis and antileishmanial evaluation of some 2,3-disubstituted-4(3H)-quinazolinone derivatives.
    Birhan YS, Bekhit AA, Hymete A.
    Org Med Chem Lett; 2014 Dec; 4(1):10. PubMed ID: 26548988
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, antimalarial, antileishmanial evaluation, and molecular docking study of some 3-aryl-2-styryl substituted-4(3H)-quinazolinone derivatives.
    Seifu GW, Birhan YS, Beshay BY, Hymete A, Bekhit AA.
    BMC Chem; 2022 Dec 02; 16(1):107. PubMed ID: 36461074
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, antileishmanial, antimalarial evaluation and molecular docking study of some hydrazine-coupled pyrazole derivatives.
    Berhe HG, Birhan YS, Beshay BY, Habib HJ, Hymete A, Bekhit AA.
    BMC Chem; 2024 Jan 08; 18(1):9. PubMed ID: 38191485
    [Abstract] [Full Text] [Related]

  • 4. Study of antileishmanial activity of 2-aminobenzoyl amino acid hydrazides and their quinazoline derivatives.
    Khattab SN, Haiba NS, Asal AM, Bekhit AA, Guemei AA, Amer A, El-Faham A.
    Bioorg Med Chem Lett; 2017 Feb 15; 27(4):918-921. PubMed ID: 28087274
    [Abstract] [Full Text] [Related]

  • 5. Antileishmanial Drug Discovery: Synthetic Methods, Chemical Characteristics, and Biological Potential of Quinazolines and its Derivatives.
    Sahu A, Kumar D, Agrawal RK.
    Antiinflamm Antiallergy Agents Med Chem; 2017 Feb 15; 16(1):3-32. PubMed ID: 28464778
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. SAR refinement of antileishmanial N(2),N(4)-disubstituted quinazoline-2,4-diamines.
    Zhu X, Van Horn KS, Barber MM, Yang S, Wang MZ, Manetsch R, Werbovetz KA.
    Bioorg Med Chem; 2015 Aug 15; 23(16):5182-9. PubMed ID: 25749014
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of natural anti-parasitic guided development of synthetic drugs for leishmaniasis.
    Pal R, Teli G, Akhtar MJ, Matada GSP.
    Eur J Med Chem; 2023 Oct 05; 258():115609. PubMed ID: 37421889
    [Abstract] [Full Text] [Related]

  • 11. 4-Arylamino-6-nitroquinazolines: Synthesis and their activities against neglected disease leishmaniasis.
    Saad SM, Ghouri N, Perveen S, Khan KM, Choudhary MI.
    Eur J Med Chem; 2016 Jan 27; 108():13-20. PubMed ID: 26619389
    [Abstract] [Full Text] [Related]

  • 12. Microwave Assisted Synthesis and Molecular Docking Studies of Some 4- (3H)-quinazolinone Derivatives as Inhibitors of Human Gamma- Aminobutyric Acid Receptor, the GABA (A)R-BETA3 Homopentamer.
    Amrutkar RD, Ranawat MS.
    Med Chem; 2021 Jan 27; 17(5):453-461. PubMed ID: 31840612
    [Abstract] [Full Text] [Related]

  • 13. Development and evaluation of a cedrol-loaded nanostructured lipid carrier system for in vitro and in vivo susceptibilities of wild and drug resistant Leishmania donovani amastigotes.
    Kar N, Chakraborty S, De AK, Ghosh S, Bera T.
    Eur J Pharm Sci; 2017 Jun 15; 104():196-211. PubMed ID: 28400285
    [Abstract] [Full Text] [Related]

  • 14. Novel β-carboline-quinazolinone hybrids disrupt Leishmania donovani redox homeostasis and show promising antileishmanial activity.
    Ramu D, Garg S, Ayana R, Keerthana AK, Sharma V, Saini CP, Sen S, Pati S, Singh S.
    Biochem Pharmacol; 2017 Apr 01; 129():26-42. PubMed ID: 28017772
    [Abstract] [Full Text] [Related]

  • 15. Efficient one-pot synthesis, molecular docking and in silico ADME prediction of bis-(4-hydroxycoumarin-3-yl) methane derivatives as antileishmanial agents.
    Zaheer Z, Khan FA, Sangshetti JN, Patil RH.
    EXCLI J; 2015 Apr 01; 14():935-47. PubMed ID: 26839526
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R, Castillo R, Hernández-Campos A, Maldonado-Rangel A, Matius-Ruiz JB, Trejo-Soto PJ, Nogueda-Torres B, Dea-Ayuela MA, Bolás-Fernández F, Méndez-Cuesta C, Yépez-Mulia L.
    Exp Parasitol; 2018 Jan 01; 184():82-89. PubMed ID: 29191699
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
    Suryawanshi SN, Kumar S, Shivahare R, Pandey S, Tiwari A, Gupta S.
    Bioorg Med Chem Lett; 2013 Sep 15; 23(18):5235-8. PubMed ID: 23910597
    [Abstract] [Full Text] [Related]

  • 18. Identification of potential antileishmanial 1,3-disubstituted-4-hydroxy-6-methylpyridin-2(1H)-ones, in vitro metabolic stability, cytotoxicity and molecular modeling studies.
    Borkar MR, Martis EAF, Nandan S, Patil RH, Shelar A, Iyer KR, Raikuvar K, Desle D, Coutinho EC.
    Chem Biol Interact; 2022 Jan 05; 351():109758. PubMed ID: 34826397
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, antileishmanial activity and molecular modeling of new 1-aryl/alkyl-3-benzoyl/cyclopropanoyl thiourea derivatives.
    Mohammadi-Ghalehbin B, Shiran JA, Gholizadeh N, Razzaghi-Asl N.
    Mol Divers; 2023 Aug 05; 27(4):1531-1545. PubMed ID: 36001225
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.